Determinants and consequences of polypharmacy in patients with a depressive disorder in later life.
Carlijn WiersemaRichard C Oude VoshaarRob H S van den BrinkHans WoutersPeter VerhaakHannie C ComijsHans W JeuringPublished in: Acta psychiatrica Scandinavica (2022)
Older patients with depression have a huge risk of polypharmacy, in particular among those with an early onset depression. As an independent risk factor for chronic depression, polypharmacy needs to be identified and managed appropriately. Findings suggest that depression moderates polypharmacy through shared risk factors, including motivational problems, anxiety, and pain. The complex interaction with somatic health burden requires physicians to prescribe medications with care.